Teva Pharmaceutical Industries

NYSE: TEVA
$8.40
+$0.28 (+3.4%)
Closing price April 3, 2020
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
Ranging from very conservative to aggressive, these Raymond James health care stock picks are good additions to long-term portfolios looking to add or increase exposure to the sector.
Lee Jackson
See why Argus believes that Teva Pharmaceutical has made progress concerning its challenges, which are already baked into the stock price.
Jon C. Ogg
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.
Jon C. Ogg
Thursday's top analyst upgrades, downgrades and initiations included Applied Materials, Cisco Systems, Cognizant Technology Solutions, Costco Wholesale, Enphase Energy, Medtronic, Shopify, Starbucks,...
Jon C. Ogg
24/7 Wall St. has put together a preview of Cisco, Lyft, Nvidia and a few of the other most anticipated quarterly reports due this week.
Chris Lange
Teva Pharmaceuticals has been under fire for its role in the opioid crisis and for pricing fixing of some drugs, often at many times their market value. Is there any sign of a turn around for this...
Douglas A. McIntyre
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Chris Lange
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Jon C. Ogg
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange